维拉德美制药 MANE
$138.78 +$10.18 (+7.92%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $139.33 +0.40%
开盘$130.93
昨收$128.60
当日区间$130.00 – $139.89
成交量503.3K
市值$5.80B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$29.55M-83.9% YoY
净利润-$23.50M-50.2% YoY
摊薄每股收益-$0.58-12.9% YoY
自由现金流-$14.51M+7.2% YoY
经营现金流-$14.49M
营收，近7个季度
净利润，近7个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-12.8%
资产收益率-12.6%
投入资本回报率-13.8%
流动比率70.53
负债/资产比率1.5%
现金及投资$819.89M
总负债$428,000.00
净现金（净负债）$819.47M
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $825.74M | $397.36M | $152.62M | $152.62M | $18.80M |
| 应收款 | $1.59M | $1.65M | $1.26M | $1.26M | $1.23M |
| -长期融资租赁负债 | $428,000.00 | $0.00 | $4,000.00 | $4,000.00 | $16,000.00 |
| 流动资产合计 | $824.75M | $397.07M | $152.49M | $152.49M | $18.71M |
| 现金及现金等价物与短期投资 | $819.89M | $390.80M | $141.86M | $141.86M | $15.14M |
| -现金及现金等价物 | $319.33M | $168.41M | $21.77M | $21.77M | $5.66M |
| -短期投资 | $500.56M | $222.39M | $120.10M | $120.10M | $9.48M |
| 一年内应计费用 | $5.40M | $5.61M | $6.98M | $6.98M | $2.60M |
| -应计应收利息 | $376,000.00 | $438,000.00 | – | – | – |
| 资本公积 | $989.26M | $543.04M | $2.35M | $2.35M | $1.36M |
| -优先股 | $0.00 | $0.00 | – | – | – |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| 股东权益 | $813.61M | $390.64M | -$121.01M | -$121.01M | -$96.02M |
| 股东权益合计 | $813.61M | $390.64M | -$121.01M | -$121.01M | -$96.02M |
| 可转换优先证券 | $0.00 | $0.00 | $264.48M | $264.48M | $109.10M |
| -应付账款 | $5.92M | $1.07M | $2.13M | $2.13M | $1.99M |
| 长期债务及融资租赁负债 | $428,000.00 | $0.00 | $4,000.00 | $4,000.00 | $16,000.00 |
| 非流动负债合计 | $428,000.00 | $0.00 | $264.48M | $264.48M | $109.12M |
| 留存收益 | -$174.16M | -$150.65M | -$123.42M | -$123.42M | -$97.38M |
| 不影响留存收益的损益 | -$895,000.00 | -$524,000.00 | $60,000.00 | $60,000.00 | – |
| 其他权益权益 | -$596,000.00 | -$1.23M | – | – | – |
| -应收税款 | $1.21M | $1.21M | $1.26M | $1.26M | $1.23M |
| 预付资产 | $2.13M | $4.02M | $5.61M | $5.61M | $2.07M |
| 一年内递延资产 | $0.00 | $0.00 | $3.39M | $3.39M | – |
| 其他流动资产 | $1.14M | $602,000.00 | $381,000.00 | $381,000.00 | $273,000.00 |
| 非流动资产合计 | $989,000.00 | $287,000.00 | $125,000.00 | $125,000.00 | $84,000.00 |
| 固定资产净值 | $989,000.00 | $287,000.00 | $125,000.00 | $125,000.00 | $84,000.00 |
| -固定资产原值 | $989,000.00 | $287,000.00 | $125,000.00 | $125,000.00 | $84,000.00 |
| 负债合计 | $12.12M | $6.72M | $273.63M | $273.63M | $114.81M |
| 流动负债合计 | $11.69M | $6.72M | $9.15M | $9.15M | $5.69M |
| 应付款 | $5.92M | $1.07M | $2.13M | $2.13M | $1.99M |
| 其他流动负债 | $379,000.00 | $39,000.00 | $47,000.00 | $47,000.00 | $1.11M |
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| 其他收入（支出） | $1.21M | – | – | – | – |
| 非经营性利息净收入（支出） | $4.84M | $2.48M | $906,000.00 | $1.56M | $71,000.00 |
| 研发费用 | $18.61M | $20.93M | $18.19M | $62.07M | $18.10M |
| -管理费用 | $10.95M | $8.94M | $4.82M | $10.28M | $2.25M |
| 销售及管理费用 | $10.95M | $8.94M | $4.82M | $10.28M | $2.25M |
| 营业费用 | $29.55M | $29.71M | $22.75M | $71.56M | $19.82M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 其他非经营性收入（支出） | $1.21M | – | – | – | – |
| 税前利润 | -$23.50M | -$27.23M | -$21.85M | -$70.00M | -$20.10M |
| 税费 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 摊薄每股收益 | -$0.58 | -$1.32 | -$0.62 | -$2.38 | -$0.64 |
| 基本每股收益 | -$0.58 | -$1.32 | -$0.62 | -$2.38 | -$0.64 |
| 归属普通股股东净利润 | -$23.50M | -$30.01M | -$28.21M | -$83.37M | -$22.57M |
| 归属母公司净利润 | -$23.50M | -$27.23M | -$21.85M | -$70.00M | -$20.10M |
| 持续经营利润 | -$23.50M | -$27.23M | -$21.85M | -$70.00M | -$20.10M |
| 净利润 | -$23.50M | -$27.23M | -$21.85M | -$70.00M | -$20.10M |
| 营业利润 | -$29.55M | -$29.71M | -$22.75M | -$71.56M | -$19.82M |
| 非经营性利息收入 | $4.84M | $2.48M | $906,000.00 | $1.56M | $71,000.00 |
| 其他营业费用 | – | -$149,000.00 | -$258,000.00 | -$790,000.00 | – |
| 优先股股息 | – | $2.78M | $6.36M | $13.38M | $2.47M |
| 非经营性利息支出 | – | – | $0.00 | $0.00 | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 优先股发行净额 | $0.00 | $0.00 | $159.43M | $151.00M | $10,000.00 |
| -应收款变动 | -$1.28M | -$1.50M | – | – | – |
| 固定资产购置及出售净额 | -$21,000.00 | $0.00 | -$24,000.00 | -$5,000.00 | $0.00 |
| -应付账款及应计费用变动 | $4.64M | -$2.43M | $4.39M | $4.52M | $881,000.00 |
| -其他流动资产变动 | -$80,000.00 | -$174,000.00 | – | – | – |
| -其他流动负债变动 | $109,000.00 | -$8,000.00 | -$39,000.00 | -$11,000.00 | -$10,000.00 |
| 投资活动现金流净额 | -$277.29M | -$101.30M | -$118.86M | -$109.78M | $15.00M |
| 持续经营投资活动现金流净额 | -$277.29M | -$101.30M | -$118.86M | -$109.78M | $15.00M |
| 投资购置及出售净额 | -$277.27M | -$101.30M | -$118.83M | -$109.77M | $15.00M |
| 筹资活动现金流 | $442.70M | $269.11M | $159.14M | $149.51M | $1.08M |
| 持续经营筹资活动现金流净额 | $442.70M | $269.11M | $159.14M | $149.51M | $1.08M |
| 普通股发行净额 | $414.34M | $269.10M | – | – | – |
| 股票期权行使所得 | $28.36M | $11,000.00 | $156,000.00 | $9,000.00 | $18,000.00 |
| 期末现金余额 | $319.33M | $168.41M | $21.77M | $21.77M | $5.66M |
| 现金净变动 | $150.92M | $146.65M | -$31.32M | $16.11M | -$2.94M |
| 期初现金余额 | $168.41M | $21.77M | $53.08M | $5.66M | $8.60M |
| 自由现金流 | -$14.51M | -$21.17M | -$71.63M | -$23.63M | -$19.01M |
| 营运资金变动 | $4.81M | $251,000.00 | -$3.89M | -$2.60M | $559,000.00 |
| 其他非现金项目 | $690,000.00 | $554,000.00 | $839,000.00 | -$154,000.00 | $392,000.00 |
| -预付资产变动 | $1.42M | $4.36M | -$8.24M | -$7.11M | -$312,000.00 |
| 持续经营净利润 | -$23.50M | -$27.23M | -$70.00M | -$21.85M | -$20.10M |
| 持续经营经营活动现金流净额 | -$14.49M | -$21.17M | -$71.60M | -$23.63M | -$19.01M |
| 经营活动现金流 | -$14.49M | -$21.17M | -$71.60M | -$23.63M | -$19.01M |
| 其他筹资费用净额 | – | – | -$447,000.00 | -$1.50M | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 MANE。
登录后参与讨论。